Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Enfermedad de Alzheimer y Demencias

6825 ARTÍCULOS , VIENDO DEL 2791 AL 2805

Which Episodic Memory Performance is Associated with Alzheimer's Disease Biomarkers in Elderly Cognitive Complainers? Evidence from a Longitudinal Observational Study with Four Episodic Memory Tests (Insight-PreAD)

Gagliardi G, Epelbaum S, Houot M, Bakardjian H, Boukadida L, Revillon M, Dubois B, Dalla Barba G, La Corte V; INSIGHT-preAD study group.

J Alzheimers Dis. 2019;70(3):811-824. doi: 10.3233/JAD-180966.

Exosome-encapsulated microRNAs as promising biomarkers for Alzheimer's disease

Chen JJ, Yang G, Yan QQ, Zhao J, Li S.

Rev Neurosci. 2019 Dec 18;31(1):77-87. doi: 10.1515/revneuro-2019-0001.

MIND food and speed of processing training in older adults with low education, the MINDSpeed Alzheimer's disease prevention pilot trial

Clark DO, Xu H, Moser L, Adeoye P, Lin AW, Tangney CC, Risacher SL, Saykin AJ, Considine RV, Unverzagt FW.

Contemp Clin Trials. 2019 Sep;84:105814. doi: 10.1016/j.cct.2019.105814. Epub 2019 Jul 18.

Association of Altered Liver Enzymes With Alzheimer Disease Diagnosis, Cognition, Neuroimaging Measures, and Cerebrospinal Fluid Biomarkers

Nho K, Kueider-Paisley A, Ahmad S, MahmoudianDehkordi S, Arnold M, Risacher SL, Louie G, Blach C, Baillie R, Han X, Kastenmüller G, Trojanowski JQ, Shaw LM, Weiner MW, Doraiswamy PM, van Duijn C, Saykin AJ, Kaddurah-Daouk R; Alzheimer’s Disease Neuroimaging Initiative and the Alzheimer Disease Metabolomics Consortium.

JAMA Netw Open. 2019 Jul 3;2(7):e197978. doi: 10.1001/jamanetworkopen.2019.7978.

Which features of subjective cognitive decline are related to amyloid pathology? Findings from the DELCODE study

Miebach L, Wolfsgruber S, Polcher A, Peters O, Menne F, Luther K, Incesoy E, Priller J, Spruth E, Altenstein S, Buerger K, Catak C, Janowitz D, Perneczky R, Utecht J, Laske C, Buchmann M, Schneider A, Fliessbach K, Kalbhen P, Heneka MT, Brosseron F, Spottke A, Roy N, Teipel SJ, Kilimann I, Wiltfang J, Bartels C, Düzel E, Dobisch L, Metzger C, Meiberth D, Ramirez A, Jessen F, Wagner M.

Alzheimers Res Ther. 2019 Jul 31;11(1):66. doi: 10.1186/s13195-019-0515-y.

Blood circulating miRNAs as biomarkers of Alzheimer's disease: a systematic review and meta-analysis

Zhang YH, Bai SF, Yan JQ.

Biomark Med. 2019 Aug;13(12):1045-1054. doi: 10.2217/bmm-2018-0341. Epub 2019 Aug 6.

Blood-based biomarkers for Down syndrome and Alzheimer's disease: A systematic review

Petersen ME, O'Bryant SE.

Dev Neurobiol. 2019 Jul;79(7):699-710. doi: 10.1002/dneu.22714. Epub 2019 Sep 3.

[New biomarkers for Alzheimer's disease in cerebrospinal fluid and blood]

Vogelgsang J, Wiltfang J.

Nervenarzt. 2019 Sep;90(9):907-913. doi: 10.1007/s00115-019-0772-9.

Cerebrospinal Fluid Correlates of Neuropsychiatric Symptoms in Patients with Alzheimer's Disease/Mild Cognitive Impairment: A Systematic Review

Showraki A, Murari G, Ismail Z, Barfett JJ, Fornazzari L, Munoz DG, Schweizer TA, Fischer CE.

J Alzheimers Dis. 2019;71(2):477-501. doi: 10.3233/JAD-190365.

Amyloid-β PET-Correlation with cerebrospinal fluid biomarkers and prediction of Alzheimer´s disease diagnosis in a memory clinic

Müller EG, Edwin TH, Stokke C, Navelsaker SS, Babovic A, Bogdanovic N, Knapskog AB, Revheim ME.

PLoS One. 2019 Aug 20;14(8):e0221365. doi: 10.1371/journal.pone.0221365. eCollection 2019.

AD biomarker discovery in CSF and in alternative matrices

Sancesario G, Bernardini S.

Clin Biochem. 2019 Oct;72:52-57. doi: 10.1016/j.clinbiochem.2019.08.008. Epub 2019 Aug 19.

A meta-analysis on CSF neurogranin levels for the diagnosis of Alzheimer's disease and mild cognitive impairment

Mavroudis IA, Petridis F, Chatzikonstantinou S, Kazis D.

Aging Clin Exp Res. 2020 Sep;32(9):1639-1646. doi: 10.1007/s40520-019-01326-z. Epub 2019 Aug 28.

The "rights" of precision drug development for Alzheimer's disease

Cummings J, Feldman HH, Scheltens P.

Alzheimers Res Ther. 2019 Aug 31;11(1):76. doi: 10.1186/s13195-019-0529-5.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias